For thanksgiving. Good morning, everyone. Welcome to bloomberg surveillance. I am Francine Lacqua here in london. The markets are little bit on the move. On the one hand, we have a vaccine and encouraging news from the pharmaceutical companies. I am looking forward to catching up with the roche chief executive on the treatment out there. On the other hand, we get infections rising in the latest one from the cdc, saying lees try not to travel for tryksgiving please not to travel for thanksgiving. U. S. Futures are actually down. The dollar edging up somewhat. If you look at, you know, health and industrial shares, they seem to be rallying here in the u. K. , and i want to show you yields on the spanish bond. I think we will have that board shortly, so we will bring you that, but you can see in general, it is a twoway system for what the market is looking at. Now lets get to the bloomberg first word news in london with leighann gerrans. Hi, leighann. Leighann hi, francine. Over in georgi
Santander s Botin defends Orcel offer as CEO row reaches court
By Emma Pinedo and Jesús Aguado
Reuters
MADRID (Reuters) -Santander boss Ana Botin defended the bank s actions in a court hearing over the withdrawal of a multi-million euro offer more than two years ago to make Italian banker Andrea Orcel its CEO.
The very public row, which judge Javier Sanchez Beltran unexpectedly suspended after a two-hour hearing on Wednesday, offered a rare glimpse into the inner workings of a major bank.
It ended up in a Madrid court after Spain s largest lender dropped plans to make Orcel, previously the top investment banker at Swiss bank UBS, chief executive as a result of a dispute over his pay package.